10-Q: Presurance Holdings Reports Q3 2026 Results Amid Revenue Decline

Sentiment:

Quarterly Report


Presurance Holdings, Inc. filed its Q3 2026 Form 10-Q, detailing a significant decrease in gross written premiums and a net loss for the quarter, though reporting net income for the nine-month period.

Summary

  • Presurance Holdings, Inc. reported a net loss of $1.6 million ($0.43 per share) for the third quarter of 2026, a significant improvement from the $4.0 million loss ($2.27 per share) in the same period of 2025.
  • For the nine months ended September 30, 2026, the company achieved a net income of $3.5 million ($1.06 per share), a substantial turnaround from a net loss of $1.4 million ($0.80 per share) in the prior year.
  • Gross written premiums for the third quarter decreased by 57.8% to $6.2 million, and for the nine-month period, they decreased by 40.8% to $30.7 million, primarily due to underwriting changes and the runoff of commercial lines.
  • Net earned premiums increased by 23.7% to $8.4 million in Q3 2026, but decreased by 20.7% to $21.2 million for the nine-month period.
  • The company's combined ratio improved significantly, from 141.2% in Q3 2025 to 113.2% in Q3 2026, and from 133.7% to 97.1% for the nine-month periods, indicating improved underwriting efficiency.
  • Other corporate expenses saw a substantial increase, rising from $0.1 million in Q3 2025 to $1.0 million in Q3 2026, and from $2.1 million to $2.9 million for the nine-month periods.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to significant revenue declines, continued net losses in the current quarter, and a substantial increase in corporate expenses, despite some positive trends in underwriting ratios and net income for the nine-month period.

Positives

  • Achieved net income of $3.5 million for the nine months ended September 30, 2026, compared to a net loss of $1.4 million in the same period of 2025.
  • The underwriting combined ratio improved significantly to 113.2% in Q3 2026 from 141.2% in Q3 2025, and to 97.1% for the nine months ended September 30, 2026, from 133.7% in the prior year.
  • Net losses and loss adjustment expenses decreased by 9.7% to $5.8 million in Q3 2026 and by 51.5% to $10.8 million for the nine-month period, largely due to the runoff of commercial lines.
  • Received $10.0 million from the third and final earnout of the CIS Sale on August 21, 2026.
  • The company's personal lines business showed a segment underwriting gain of $1.5 million in Q3 2026, a significant improvement from a $0.3 million gain in Q3 2025.
  • Total shareholders' equity increased to $24.2 million as of September 30, 2026, from $9.0 million as of December 31, 2025.

Negatives

  • Reported a net loss of $1.6 million for the third quarter of 2026.
  • Gross written premiums decreased significantly by 57.8% in Q3 2026 and 40.8% for the nine-month period.
  • Net earned premiums decreased by 20.7% for the nine-month period ended September 30, 2026.
  • Other corporate expenses increased substantially by 566.4% in Q3 2026 and 38.6% for the nine-month period.
  • The company's commercial lines business is in runoff, contributing to a significant decrease in gross written premiums.
  • Cash used in operating activities increased by $9.0 million for the nine months ended September 30, 2026, to $27.7 million.

Risks

  • Failure of reinsurers to honor their obligations could result in losses to the Company.
  • The Company may not obtain any additional recoveries from the loss portfolio transfer due to the insolvency of the reinsurer.
  • The Company is subject to various claims, lawsuits, and proceedings that could result in significant damages.
  • The Company's ability to service debt and preferred stock is reliant on intercompany service fees from its insurance subsidiaries, which have been minimal.
  • State insurance laws restrict the ability of insurance subsidiaries to declare dividends to the parent company.
  • The Company's insurance subsidiaries may be subject to regulatory monitoring requirements due to risk-based capital levels.

Future Outlook

Management believes the Company has the ability to meet its obligations over the next twelve months, supported by the recent receipt of the final earnout payment and anticipated future revenue from TIC.

Management Comments

  • The Company's main focus remains on prudent, steady growth in Texas.
  • The Company does not expect to write any commercial lines business in the near term as these lines are in runoff.
  • The increase in other corporate expenses for Q3 2026 was more consistent with the Company's normal trend, compared to Q3 2025 which had favorably adjusted corporate expense accruals.
  • The decrease in operating expenses as a percent of net earned premiums was mostly due to improved administrative cost efficiency.

Industry Context

StockSavvy.ai notes that the insurance industry is experiencing shifts, with a focus on specialty lines and a move away from traditional commercial business for some carriers. Presurance Holdings' strategy of focusing on personal lines in Texas and running off commercial lines aligns with this trend, though the significant decrease in premiums indicates a challenging transition period.

Comparison to Industry Standards

  • The combined ratio for Q3 2026 (113.2%) and the nine-month period (97.1%) shows a significant improvement, with the nine-month ratio falling below the 100% threshold indicating profitability. This improvement is notable given the industry's sensitivity to underwriting performance.
  • The decline in gross written premiums is a significant concern, as it suggests a shrinking market presence or a strategic pivot that has not yet translated into growth in the core business. Competitors focusing on growth in specialty personal lines might be experiencing different premium trends.
  • The increase in other corporate expenses, while explained by management as normalization, could be a point of concern if not managed effectively, as it impacts overall profitability and can be a drag on investor sentiment compared to peers with more streamlined corporate overhead.

Legal Proceedings

  • A shareholder filed a complaint alleging breaches of fiduciary duties and Michigan law concerning the sale of Series B and Series C Preferred Stock and warrants to Clarkston 91 West and its affiliate. The company believes the lawsuit is without merit.

Related Party Transactions

  • Series D Preferred Stock issued to Clarkston Companies, Inc., an entity affiliated with Jeffrey Hakala, a member of the Board of Directors.
  • Series C Preferred Stock issued to Clarkston Companies, Inc., an entity affiliated with Jeffrey Hakala, a member of the Board of Directors.
  • Series B Preferred Stock issued to Clarkston 91 West LLC, an entity affiliated with Gerald and Jeffrey Hakala, former members of the Board of Directors.
  • Rights offering backstopped by Clarkston Companies, Inc.

Stakeholder Impact

  • Shareholders: The net loss in Q3 2026 and continued revenue decline may negatively impact share price, while the nine-month net income and improved combined ratio could be viewed positively.
  • Creditors: The company's ability to meet obligations is noted as manageable for the next twelve months, but reliance on asset sales and capital raises highlights potential future liquidity concerns.
  • Employees: The shift to personal lines and runoff of commercial lines may lead to restructuring or changes in workforce focus.
  • Regulators: The company's insurance subsidiaries are subject to regulatory monitoring due to risk-based capital levels, which could impact operational flexibility.

Next Steps

  • Continue to focus on prudent, steady growth in Texas for personal lines insurance products.
  • Manage the runoff of commercial lines of business.
  • Monitor and manage regulatory requirements related to risk-based capital levels.
  • Utilize proceeds from the CIS Sale earnout for working capital and general corporate purposes.

Key Dates

DateDescription
2025-04-02Maturity date for Series D Preferred Stock (originally Series C).
2025-12-23Issuance of Series C Preferred Stock.
2026-02-27Redemption of Series B Preferred Stock and completion of a rights offering.
2026-05-11Exchange of Series C Preferred Stock for Series D Preferred Stock.
2026-06-01Effective date of a property catastrophe reinsurance treaty and a 1-for-7 reverse stock split.
2026-08-21Receipt of the third and final earnout from the CIS Sale.
2026-09-30Quarterly period end for the reported financial statements.
2026-11-12Date of the filing of the Form 10-Q.

Recommendation

hold

The company shows signs of operational improvement with a significantly better combined ratio and net income for the nine-month period. However, the substantial decline in gross written premiums and the net loss in the current quarter, coupled with increased corporate expenses, present considerable risks. A 'hold' recommendation reflects a cautious approach, awaiting sustained revenue growth and consistent profitability before considering a more positive outlook.

Keywords

insurance, property and casualty, underwriting, premiums, reinsurance, loss reserves, financial statements, quarterly report

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.